UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of May 2026
Commission File Number: 001-41411
Haleon plc
(Translation
of registrant’s name into English)
Building 5, First Floor, The Heights,
Weybridge, Surrey, KT13 0NY
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F:
EXHIBIT INDEX
|
Exhibit
Number
|
Description
|
|
99.1
|
07 May
2026 - “EMTN programme
publication of listing particulars”
|
99.1
Haleon plc: EMTN programme - Publication of listing
particulars
7 May 2026: Haleon
plc (the "Company" or "Haleon") announces that, following a routine
annual update, listing particulars dated 7 May 2026 regarding
Haleon UK Capital plc's and Haleon Netherlands Capital B.V.'s
£10,000,000,000 Euro Medium Term Note ("EMTN") Programme,
guaranteed by the Company, have been published (the "Listing
Particulars").
A copy of the Listing Particulars is available for inspection and
can be downloaded from www.haleon.com/investors/debt-investors.
Amanda Mellor
Company Secretary
Enquiries
|
Investors
|
Media
|
|
Jo
Russell
|
+44
7787 392441
|
Zoë Bird
|
+44
7736 746167
|
|
Rakesh
Patel
|
+44
7552 484646
|
Victoria
Durman
|
+44 7894 505730
|
|
Email: investor-relations@haleon.com
|
Email: corporate.media@haleon.com
|
About Haleon
Haleon (LSE/NYSE: HLN) is a consumer company that is solely focused
on better everyday health. Our people, our brands, our research,
our investment and our innovation are aimed at improving the
everyday health of consumers. Our product portfolio spans six major
categories - Oral Health, Vitamins, Minerals and Supplements (VMS),
Pain Relief, Respiratory Health, Digestive Health and Therapeutic
Skin Health and Other. Our superior brands - such
as Advil, Centrum, Otrivin,
Panadol, parodontax, Polident, Sensodyne,
Theraflu and Voltaren - are trusted by more than one billion
consumers and are recommended by health professionals around the
world.
For more information, please visit www.haleon.com.
Disclaimer
Please note that the information contained in the Listing
Particulars may be addressed to and/or targeted at persons who are
residents of particular countries (specified in the Listing
Particulars) only and is not intended for use and should not be
relied upon by any person outside these countries and/or to whom
the offer contained in the Listing Particulars is not addressed.
Prior to relying on the information contained in the Listing
Particulars, you must ascertain from the Listing Particulars
whether or not you are part of the intended addressees of the
information contained in the Listing Particulars.
Your right to access this service is conditional upon complying
with the above requirement.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
|
|
HALEON PLC
(Registrant)
|
|
Date:
May 07, 2026
|
By:
|
/s/
Amanda Mellor
|
|
|
|
Name:
|
Amanda
Mellor
|
|
|
|
Title:
|
Company
Secretary
|